| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $6.5M | -13.3% |
| SG&A Expense | $3.5M | -53.1% |
| Operating Income | -$9.9M | +33.2% |
| Interest Expense | $10K | +31.2% |
| Pre-tax Income | -$9.9M | +33.1% |
| Net Income | -$9.9M | +33.1% |
| EPS (Basic) | -$14.70 | -9700.0% |
| EPS (Diluted) | -$14.70 | -9700.0% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $376K | -92.7% |
| Current Assets | $455K | -92.2% |
| Total Assets | $632K | -89.3% |
| Total Liabilities | $3.2M | +12.4% |
| Stockholders' Equity | -$2.6M | -185.2% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | +7.3% |
| Investing Cash Flow | -$147K | — |
| Financing Cash Flow | $3.7M | — |